BioMarin Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
26.02.26
/
50%
€51.78
Target price
26.02.27
€87.99
Performance (%)
-11.32%
Price
16.04.26
€45.92
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -11.32%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.572% | -4.572% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) was given a new $104.00 price target by Canaccord Genuity Group Inc.. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat